Source:http://linkedlifedata.com/resource/pubmed/id/14565538
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-10-20
|
pubmed:abstractText |
1. Experiments were undertaken to determine if the imidazoline/alpha2-adrenoceptor agonist, rilmenidine, would produce mydriasis in cats and, if so, to delineate its site of action and determine if this effect is mediated by imidazoline receptors or alpha2-adrenoceptors. 2. Rilmenidine produced dose-related pupillary dilator responses in pentobarbital anaesthetized cats that were independent of sympathetic innervation to the iris but were dependent upon intact parasympathetic neuronal tone. The ED50 for rilmenidine-induced pupillary dilation was approximately 200 microg kg(-1), i.v., and was sustained for at least 1 h. 3. The highly selective alpha2-adrenoceptor antagonist, RS-79948, administered either before or after rilmenidine, antagonized rilmenidine-induced mydriasis. Neuronally induced reflex inhibition of parasympathetic nerve activity was also inhibited by administration of RS-79948. 4. These results suggest that rilmenidine acts like clonidine to produce pupillary dilation by inhibition of parasympathetic tone to the iris sphincter and that this central nervous system parasympatho-inhibition is mediated by alpha2-adrenoceptors, rather than imidazoline receptors.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-2 Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Mydriatics,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha-2,
http://linkedlifedata.com/resource/pubmed/chemical/rilmenidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1474-8665
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:14565538-Adrenergic alpha-2 Receptor Agonists,
pubmed-meshheading:14565538-Animals,
pubmed-meshheading:14565538-Cats,
pubmed-meshheading:14565538-Central Nervous System,
pubmed-meshheading:14565538-Dose-Response Relationship, Drug,
pubmed-meshheading:14565538-Female,
pubmed-meshheading:14565538-Male,
pubmed-meshheading:14565538-Mydriatics,
pubmed-meshheading:14565538-Oxazoles,
pubmed-meshheading:14565538-Pupil,
pubmed-meshheading:14565538-Receptors, Adrenergic, alpha-2
|
pubmed:year |
2003
|
pubmed:articleTitle |
Rilmenidine produces mydriasis in cats by stimulation of CNS alpha 2-adrenoceptors.
|
pubmed:affiliation |
Department of Cell Biology, University of Oklahoma College of Medicine, PO Box 26901, Oklahoma City, OK 73190, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|